| |
| |
|
| Insider
Information: |
Novak Rodger |
| Relationship: |
President, Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
573,007 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$34,374,690 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
573,007 |
|
|
| Total
Value |
$34,374,690 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Crispr Therapeutics Ag |
CRSP |
President, Director |
2021-06-30 |
573,007 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
67 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2017-04-19 |
4 |
AS |
$17.57 |
$854,066 |
D/D |
(47,706) |
1,215,005 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2017-04-20 |
4 |
AS |
$17.37 |
$39,852 |
D/D |
(2,294) |
1,215,005 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2017-05-02 |
4 |
AS |
$16.53 |
$263,236 |
D/D |
(15,924) |
1,215,005 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2017-05-03 |
4 |
AS |
$16.05 |
$325,986 |
D/D |
(20,269) |
1,215,005 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2017-05-04 |
4 |
AS |
$16.37 |
$215,960 |
D/D |
(13,191) |
1,215,005 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2017-05-05 |
4 |
AS |
$16.92 |
$10,426 |
D/D |
(616) |
1,215,005 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2017-05-16 |
4 |
AS |
$16.50 |
$397,283 |
D/D |
(24,077) |
1,215,005 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2017-05-17 |
4 |
AS |
$16.03 |
$415,577 |
D/D |
(25,923) |
1,215,005 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2017-05-30 |
4 |
AS |
$15.02 |
$54,829 |
D/D |
(3,650) |
1,215,005 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2017-06-08 |
4 |
AS |
$15.00 |
$63,045 |
D/D |
(4,203) |
1,215,005 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2017-06-09 |
4 |
AS |
$15.08 |
$16,583 |
D/D |
(1,100) |
1,215,005 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2017-06-19 |
4 |
AS |
$15.00 |
$230,880 |
D/D |
(15,392) |
1,215,005 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2017-06-20 |
4 |
AS |
$15.00 |
$48,785 |
D/D |
(3,252) |
1,215,005 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2017-06-21 |
4 |
AS |
$15.02 |
$173,846 |
D/D |
(11,578) |
1,215,005 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2017-06-22 |
4 |
AS |
$15.37 |
$166,388 |
D/D |
(10,825) |
1,215,005 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2017-08-28 |
4 |
AS |
$20.06 |
$354,919 |
D/D |
(17,692) |
1,215,005 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2017-08-30 |
4 |
AS |
$20.31 |
$1,179,950 |
D/D |
(58,103) |
1,162,624 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2017-08-31 |
4 |
AS |
$20.87 |
$305,073 |
D/D |
(14,617) |
1,148,007 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2017-09-05 |
4 |
AS |
$20.33 |
$78,320 |
D/D |
(3,853) |
1,148,007 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
President |
• • – |
2018-05-17 |
4 |
AS |
$60.00 |
$4,500,000 |
D/D |
(75,000) |
1,148,007 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
President |
• • – |
2019-01-08 |
4 |
AS |
$35.09 |
$607,408 |
D/D |
(17,310) |
1,130,697 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
President |
• • – |
2019-01-09 |
4 |
AS |
$35.01 |
$2,894,977 |
D/D |
(82,690) |
1,048,007 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
President |
• • – |
2019-02-25 |
4 |
AS |
$40.00 |
$591,233 |
D/D |
(14,780) |
1,033,227 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
President |
• • – |
2019-03-01 |
4 |
AS |
$40.01 |
$347,796 |
D/D |
(8,693) |
1,024,534 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
President |
• • – |
2019-03-04 |
4 |
AS |
$40.24 |
$3,095,240 |
D/D |
(76,527) |
948,007 |
0 |
- |
|
67 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
